US FDA conducting inspection at Samsung Biologics facilities in South Korea
4 Articles
4 Articles
US FDA conducting inspection at Samsung Biologics facilities in South Korea
The U.S. Food and Drug Administration (FDA) is currently conducting an on-site inspection of Samsung Biologics's production facilities in Korea, industry sources said Wednesday. According to the sourc...
Insourcing Cell-line Development Streamlines Antibody Biomanufacturing
Insourcing cell-line development has helped a fast-growing antibody manufacturer to deliver process improvements and strengthen communication with their contract manufacturer, according to Genmab, based in Denmark. The company says its choice to insource cell-line operations, rather than relying on a CDMO, helped them accelerate cell-line development and improve their antibody titers. “We’re interested in new technology and, by insourcing and fr…
US FDA conducts inspection at Samsung Biologics facilities in S. Korea: Report - tennews.in: National News Portal
Seoul, May 21 (IANS) The US Food and Drug Administration (FDA) is currently conducting an on-site inspection of Samsung Biologics’ production facilities in South Korea, industry sources said Wednesday. According to the sources, the FDA launched the inspection at the company’s facilities in Songdo, west of Seoul, and is scheduled to continue through Tuesday, Yonhap […] The post US FDA conducts inspection at Samsung Biologics facilities in S. Kore…
US FDA inspects Samsung Biologics facilities in South Korea –...
Last Updated on May 21, 2025 by Team THIP Seoul, May 21 (IANS) The US Food and Drug Administration (FDA) is currently conducting an on-site inspection of Samsung Biologics’ production facilities in South Korea, industry sources said on Wednesday. According to the sources, the FDA launched the inspection at the company’s facilities in Songdo, west […] The post US FDA inspects Samsung Biologics facilities in South Korea appeared first on THIP Medi…
Coverage Details
Bias Distribution
- 100% of the sources lean Left
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage